| --- |
| configs: |
| - config_name: default |
| data_files: |
| - split: train |
| path: data/train-* |
| - split: validation |
| path: data/validation-* |
| - split: test |
| path: data/test-* |
| license: unknown |
| tags: |
| - medical-imaging |
| - cystoscopy |
| - bladder-cancer |
| - cancer-detection |
| - histological-grade |
| pretty_name: Unified Cystoscopy Cancer Detection (Dataset E) |
| size_categories: |
| - 10K<n<100K |
| dataset_info: |
| features: |
| - name: image |
| dtype: image |
| - name: cancer_label |
| dtype: |
| class_label: |
| names: |
| '0': non_cancer |
| '1': cancer |
| - name: grade_label |
| dtype: |
| class_label: |
| names: |
| '0': low_grade |
| '1': high_grade |
| '2': not_applicable |
| - name: subclass_label |
| dtype: |
| class_label: |
| names: |
| '0': malignant |
| '1': non_malignant |
| '2': normal |
| '3': landmark |
| '4': foreign_body |
| - name: source_dataset |
| dtype: string |
| - name: original_filename |
| dtype: string |
| - name: patient_id |
| dtype: int32 |
| - name: imaging_type |
| dtype: |
| class_label: |
| names: |
| '0': WLI |
| '1': NBI |
| '2': BLC |
| - name: target3 |
| dtype: |
| class_label: |
| names: |
| '0': malignant |
| '1': non_malignant |
| '2': non_roi |
| - name: track_id |
| dtype: string |
| - name: cv_fold |
| dtype: int32 |
| splits: |
| - name: train |
| num_examples: 10436 |
| - name: validation |
| num_examples: 2244 |
| - name: test |
| num_examples: 2241 |
| --- |
| |
| # Unified Cystoscopy Cancer Detection (Dataset E) |
|
|
| ## Dataset Description |
|
|
| A unified cystoscopy image dataset assembled from three independent sources, |
| prepared for 3-class deep learning (malignant vs non-malignant vs non-ROI). |
| Every image carries a **cancer label**, a **grade label**, a **subclass label**, |
| and a derived **target3** label for the 3-class task. |
|
|
| - **Total images (after capping)**: 14,921 |
| - **Unique patients/cases**: 212 |
| - **Modalities**: White-Light Imaging (WLI), Narrow-Band Imaging (NBI), Blue-Light Cystoscopy (BLC) |
| - **Splits**: train / validation / test (70 / 15 / 15), patient-level with no leakage |
|
|
| ## Source Datasets |
|
|
| | Code | Source | Type | Images (raw) | Images (after cap) | Patients/Cases | |
| |------|--------|------|-------------:|--------------------:|----------------:| |
| | B | Cystoscopy video dataset | Video frames (stride 8) | 6,519 | 5,100 | 30 | |
| | C | CystoDS | Still cystoscopy images | 8,067 | 8,067 | 160 | |
| | D | Kaggle cystoscopy frames | Still cystoscopy frames | 1,754 | 1,754 | 22 | |
|
|
| ### Source B frame capping |
|
|
| Source B video frames are temporally autocorrelated (stride 8 extraction). |
| To reduce redundancy, majority-class frames (malignant + non-ROI) are capped |
| at **60 per (patient, track)**. Non-malignant frames are always kept. |
| This reduces source B from 6,519 to 5,100 images (cap=60, seed=42). |
|
|
| ### Patient ID normalization |
|
|
| | Source | Original ID field | Normalized range | Count | |
| |--------|-------------------|-----------------|------:| |
| | B | `patient_id` (0-29) | 1-30 | 30 | |
| | C | `pid` | 31-190 | 160 | |
| | D | `case_id` (0-25) | 191-212 | 22 | |
|
|
| ## Label Derivation |
|
|
| ### cancer_label (ClassLabel: `non_cancer`=0, `cancer`=1) |
|
|
| | Source | Field used | Mapping | |
| |--------|-----------|---------| |
| | D | `tissue_type` | HGC, LGC -> cancer; NST, NTL -> non_cancer | |
| | C | `class` | Malignant -> cancer; all others -> non_cancer | |
| | B | per-frame tumor annotation (`y`) + `histological_type` | y=1 (carcinoma patient) -> cancer; y=0 or PUNLMP -> non_cancer | |
| |
| ### grade_label (ClassLabel: `low_grade`=0, `high_grade`=1, `not_applicable`=2) |
|
|
| | Source | Field used | High-grade (1) | Low-grade (0) | Not applicable (2) | |
| |--------|-----------|----------------|---------------|---------------------| |
| | D | `tissue_type` | HGC | LGC | NST, NTL | |
| | C | `subclass` | HighGradePapillary, CIS | LowGradePapillary | all other classes | |
| | B | `histological_type` (patient-level) | pT1HG, pTaHG, pT2, pT2HG | pTaLG, pT1LG | PUNLMP, non-tumor frames (y=0) | |
|
|
| ### subclass_label (ClassLabel: `malignant`=0, `non_malignant`=1, `normal`=2, `landmark`=3, `foreign_body`=4) |
| |
| | Source | Native field | Mapping | |
| |--------|-------------|---------| |
| | B | `histological_type` + `y` | Carcinoma + y=1 -> malignant; PUNLMP -> non_malignant; y=0 -> normal | |
| | C | `class` | Malignant -> malignant; Non-malignant -> non_malignant; Normal mucosa -> normal; Anatomical landmarks -> landmark; Foreign bodies -> foreign_body | |
| | D | `tissue_type` | HGC, LGC -> malignant; NTL -> non_malignant; NST -> normal | |
| |
| ### target3 (ClassLabel: `malignant`=0, `non_malignant`=1, `non_roi`=2) |
| |
| Derived 3-class label for the deep learning task: |
| |
| | subclass_label | target3 | |
| |----------------|---------| |
| | malignant (0) | malignant (0) | |
| | non_malignant (1) | non_malignant (1) | |
| | normal (2) | non_roi (2) | |
| | landmark (3) | non_roi (2) | |
| | foreign_body (4) | non_roi (2) | |
|
|
| ### imaging_type (ClassLabel: `WLI`=0, `NBI`=1, `BLC`=2) |
| |
| | Source | Original field | Values -> unified | |
| |--------|---------------|------------------| |
| | B | `light_mode` | CLARA + CHROMA -> WLI, white light -> WLI | |
| | C | `modality` | WLC -> WLI, BLC -> BLC | |
| | D | `imaging_type` | WLI -> WLI, NBI -> NBI | |
|
|
| ## Train / Validation / Test Split |
|
|
| Patient-level stratified split using StratifiedGroupKFold (source x dominant-class |
| stratification) + post-split patient swapping to minimize fill-ratio deviation. |
|
|
| - **Split ratio**: 70 / 15 / 15 (train / val / test) |
| - **Seed**: 16 |
| - **Swaps applied**: 14 |
| - **No patient appears in more than one split** (verified) |
|
|
| ### Split sizes |
|
|
| | Split | Images | Patients | |
| |-------|-------:|---------:| |
| | train | 10,436 | 148 | |
| | validation | 2,244 | 35 | |
| | test | 2,241 | 29 | |
| | **Total** | **14,921** | **212** | |
|
|
| ### Class distribution per split |
|
|
| | Class | Total | Train | Val | Test | |
| |-------|------:|------:|----:|-----:| |
| | malignant | 6,515 (43.7%) | 4,568 | 982 | 965 | |
| | non_malignant | 900 (6.0%) | 631 | 135 | 134 | |
| | non_roi | 7,506 (50.3%) | 5,237 | 1,127 | 1,142 | |
|
|
| ### Fill ratios (count / target, ideal = 1.00) |
|
|
| | Class | Train | Val | Test | |
| |-------|------:|----:|-----:| |
| | malignant | 1.00 | 1.00 | 0.99 | |
| | non_malignant | 1.00 | 1.00 | 0.99 | |
| | non_roi | 1.00 | 1.00 | 1.01 | |
|
|
| ### Source x split (patients) |
|
|
| | Source | Train | Val | Test | |
| |--------|------:|----:|-----:| |
| | B | 21 | 4 | 5 | |
| | C | 115 | 25 | 20 | |
| | D | 12 | 6 | 4 | |
|
|
| ### Source x split (images) |
|
|
| | Source | Train | Val | Test | |
| |--------|------:|----:|-----:| |
| | B | 3,763 | 760 | 577 | |
| | C | 5,821 | 1,129 | 1,117 | |
| | D | 852 | 355 | 547 | |
|
|
| ### Non-malignant patient coverage |
|
|
| | Split | Patients | Images | |
| |-------|---------:|-------:| |
| | train | 55 | 631 | |
| | validation | 12 | 135 | |
| | test | 13 | 134 | |
|
|
| ## 5-Fold Cross-Validation (train pool only) |
|
|
| StratifiedGroupKFold on the train split (per-image `target3` stratification, |
| patient-level grouping, no patient in multiple folds, seed=15). |
|
|
| | Fold | Patients | Images | Malignant | Non-mal | Non-ROI | |
| |-----:|---------:|-------:|----------:|--------:|--------:| |
| | 0 | 26 | 2,028 | 914 | 61 | 1,053 | |
| | 1 | 35 | 2,119 | 913 | 170 | 1,036 | |
| | 2 | 31 | 2,026 | 915 | 61 | 1,050 | |
| | 3 | 26 | 2,026 | 913 | 61 | 1,052 | |
| | 4 | 30 | 2,237 | 913 | 278 | 1,046 | |
|
|
| The `cv_fold` column is -1 for validation and test patients. |
|
|
| ### Note on minority-class (non-malignant) fold balance |
|
|
| Non-malignant images are heavily patient-concentrated in this dataset: in the |
| train pool, two patients alone account for around 70% of all non-malignant images |
| (274 and 168 images respectively), and only 17 of 148 train patients are |
| non-malignant dominant. Because cross-validation is patient-grouped (a patient |
| never appears in more than one fold), these high-volume patients cannot be |
| split across folds and inevitably land in a single fold each. As a result, |
| two folds carry an elevated non-malignant proportion (~8% and ~12%) while the |
| other three sit at ~3%, against a train-pool baseline of ~6%. |
|
|
| This is an inherent limitation of the dataset's patient-level grouping, not of |
| the splitting algorithm. StratifiedGroupKFold guarantees that every fold's |
| *training* portion contains non-malignant-dominant patients and keeps the |
| majority classes (malignant, non-ROI) near-perfectly balanced across folds |
| (malignant spread: 913-915; non-ROI spread: 1,036-1,053). Practitioners should |
| report per-fold non-malignant counts alongside metrics and prefer the |
| macro-averaged F1 across all five folds over any single fold's score when |
| estimating minority-class performance. |
|
|
| ## Dataset Statistics (after capping) |
|
|
| ### By target3 |
|
|
| | Malignant | Non-malignant | Non-ROI | |
| |----------:|--------------:|--------:| |
| | 6,515 | 900 | 7,506 | |
|
|
| ### By subclass label |
|
|
| | Malignant | Non-malignant | Normal | Landmark | Foreign body | |
| |----------:|--------------:|-------:|---------:|-------------:| |
| | 6,515 | 900 | 7,044 | 211 | 251 | |
|
|
| ### By cancer label |
|
|
| | Total | Cancer | Non-cancer | |
| |------:|-------:|-----------:| |
| | 14,921 | 6,514 | 8,407 | |
|
|
| ### By grade label |
|
|
| | High-grade | Low-grade | Not applicable | |
| |-----------:|----------:|---------------:| |
| | 2,205 | 4,309 | 8,407 | |
|
|
| ### By imaging modality |
|
|
| | WLI | NBI | BLC | |
| |----:|----:|----:| |
| | 14,150 | 321 | 450 | |
|
|
| ## Features Schema |
|
|
| | Column | Type | Description | |
| |--------|------|-------------| |
| | `image` | Image | Cystoscopy image (decoded as PIL Image on load) | |
| | `cancer_label` | ClassLabel | `non_cancer` (0) / `cancer` (1) | |
| | `grade_label` | ClassLabel | `low_grade` (0) / `high_grade` (1) / `not_applicable` (2) | |
| | `subclass_label` | ClassLabel | `malignant` (0) / `non_malignant` (1) / `normal` (2) / `landmark` (3) / `foreign_body` (4) | |
| | `source_dataset` | string | `B`, `C`, or `D` -- original source dataset | |
| | `original_filename` | string | Filename in the original source dataset | |
| | `patient_id` | int32 | Normalized sequential patient/case ID (1-212) | |
| | `imaging_type` | ClassLabel | `WLI` (0) / `NBI` (1) / `BLC` (2) | |
| | `target3` | ClassLabel | `malignant` (0) / `non_malignant` (1) / `non_roi` (2) -- 3-class task label | |
| | `track_id` | string | Source B video track ID (e.g. `008`); `NA` for sources C and D | |
| | `cv_fold` | int32 | 5-fold CV assignment (0-4) for train patients; -1 for val/test | |
|
|
| ## Loading |
|
|
| ```python |
| from datasets import load_dataset |
| |
| ds = load_dataset("milkyroad/E") |
| print(ds) |
| # DatasetDict({ |
| # train: 10,436 images |
| # validation: 2,244 images |
| # test: 2,241 images |
| # }) |
| |
| # Access a sample |
| sample = ds["train"][0] |
| print(sample["target3"]) # 0 (malignant), 1 (non_malignant), or 2 (non_roi) |
| ``` |
|
|